UBS Group’s Meredith Corporation MDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-19,580
| Closed | -$1.09M | – | 11316 |
|
|
2021
Q3 | $1.09M | Sell |
19,580
-1,159
| -6% | -$50.6K | ﹤0.01% | 4131 |
|
|
2021
Q2 | $901K | Sell |
20,739
-2,559
| -11% | -$90.8K | ﹤0.01% | 4265 |
|
|
2021
Q1 | $694K | Sell |
23,298
-31,032
| -57% | -$819K | ﹤0.01% | 4593 |
|
|
2020
Q4 | $1.04M | Sell |
54,330
-6,750
| -11% | -$110K | ﹤0.01% | 3986 |
|
|
2020
Q3 | $801K | Sell |
61,080
-66,070
| -52% | -$923K | ﹤0.01% | 3803 |
|
|
2020
Q2 | $1.85M | Buy |
127,150
+40,281
| +46% | +$587K | ﹤0.01% | 2951 |
|
|
2020
Q1 | $1.06M | Sell |
86,869
-164,991
| -66% | -$4.38M | ﹤0.01% | 3296 |
|
|
2019
Q4 | $8.18M | Buy |
251,860
+184,185
| +272% | +$6.55M | ﹤0.01% | 2138 |
|
|
2019
Q3 | $2.48M | Buy |
67,675
+39,292
| +138% | +$1.83M | ﹤0.01% | 3091 |
|
|
2019
Q2 | $1.56M | Buy |
28,383
+16,191
| +133% | +$906K | ﹤0.01% | 3373 |
|
|
2019
Q1 | $674K | Sell |
12,192
-3,293
| -21% | -$183K | ﹤0.01% | 3852 |
|
|
2018
Q4 | $804K | Sell |
15,485
-2,346
| -13% | -$127K | ﹤0.01% | 3881 |
|
|
2018
Q3 | $910K | Sell |
17,831
-44,873
| -72% | -$2.35M | ﹤0.01% | 3933 |
|
|
2018
Q2 | $3.2M | Buy |
62,704
+25,396
| +68% | +$1.3M | ﹤0.01% | 2736 |
|
|
2018
Q1 | $2.01M | Sell |
37,308
-1,800
| -5% | -$107K | ﹤0.01% | 3144 |
|
|
2017
Q4 | $2.58M | Sell |
39,108
-39,807
| -50% | -$2.4M | ﹤0.01% | 2973 |
|
|
2017
Q3 | $4.38M | Buy |
78,915
+4,842
| +7% | +$274K | ﹤0.01% | 2337 |
|
|
2017
Q2 | $4.4M | Buy |
74,073
+10,077
| +16% | +$588K | ﹤0.01% | 2259 |
|
|
2017
Q1 | $4.13M | Sell |
63,996
-15,057
| -19% | -$927K | ﹤0.01% | 2252 |
|
|
2016
Q4 | $4.68M | Buy |
79,053
+53,478
| +209% | +$2.81M | ﹤0.01% | 2156 |
|
|
2016
Q3 | $1.33M | Sell |
25,575
-37,119
| -59% | -$1.98M | ﹤0.01% | 3202 |
|
|
2016
Q2 | $3.25M | Buy |
62,694
+46,314
| +283% | +$2.29M | ﹤0.01% | 2368 |
|
|
2016
Q1 | $778K | Sell |
16,380
-235,799
| -94% | -$10M | ﹤0.01% | 3455 |
|
|
2015
Q4 | $10.9M | Sell |
252,179
-63,774
| -20% | -$2.87M | 0.01% | 1344 |
|
|
2015
Q3 | $13.5M | Buy |
315,953
+208,666
| +194% | +$9.94M | 0.01% | 1165 |
|
|
2015
Q2 | $5.6M | Buy |
107,287
+93,483
| +677% | +$4.95M | ﹤0.01% | 1963 |
|
|
2015
Q1 | $770K | Sell |
13,804
-33,003
| -71% | -$1.77M | ﹤0.01% | 3797 |
|
|
2014
Q4 | $2.54M | Buy |
+46,807
| New | +$2.34M | ﹤0.01% | 2670 |
|
Other funds holding MDP
UBS Group's MDP Position: Q4 2021 in Review
UBS Group sold out of Meredith Corporation (MDP) in Q4 2021, closing a stake of 19,580 shares — an estimated $1.09M sold.
UBS Group first reported a position in MDP in Q4 2014 and held it in 28 quarters. The position peaked at $13.5M in Q3 2015. 1 fund tracked by Wall St. Rank holds MDP as of Q4 2021.
- UBS Group reported no remaining Meredith Corporation position as of Q4 2021 after selling out during the quarter.
- UBS Group sold 19,580 Meredith Corporation shares in Q4 2021, an estimated $1.09M.
- UBS Group first reported a position in Meredith Corporation in Q4 2014 and held it in 28 quarters.
- UBS Group's Meredith Corporation position peaked at $13.5M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Meredith Corporation as of Q4 2021.
Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.